Sexual Function in High-risk Pregnant Women

Anxiety Clinical Trial

Official title:

Evaluation of Sexual Function in High-risk Pregnant Women

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06130150
• Other study ID #: KBU-EMEKLIOGLU-002
• Status: Recruiting
• Start date: July 10, 2021
• Est. completion date: January 2024

Study information

• Verified date: November 2023
• Source: Karabuk University
• Contact: Cagdas Nurettin Emeklioglu, MD
• Phone: +905359129913
• Email: c.n.emeklioglu[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Our aim with this study is to evaluate the sexual functions of pregnant women whose pregnancies are defined as high-risk pregnancies and whose pregnancies are followed by perinatology specialists.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 400
• Est. completion date: January 2024
• Est. primary completion date: January 10, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria: - Pregnant women over 18 years old, -Pregnant women 39 years old and under, -Pregnant women in their 3rd trimester. Exclusion Criteria: - Pregnant women under 18 years old, -Pregnant women over 40 years old, -Pregnant women in their 1st or 2nd trimester.

Related Conditions & MeSH terms

• Anxiety
• Female Sexual Function
• High Risk Pregnancy
• Sexual Dysfunction

Locations

Country	Name	City	State
Turkey	Prof. Dr. Cemil Tascioglu City Hospital	Istanbul	Sisli

Sponsors (1)

Lead Sponsor	Collaborator
Karabuk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	1	High-risk pregnant women have lower FSFI score results then normal pregnant women	1 day